Thermal ablation in colorectal liver metastases-the paradox of equipoise  

作　　者：Nalinie Joharatnam-Hogan Khurum Khan 

机构地区：[1]Department of Gastrointestinal Oncology,University College London Hospitals NHS Foundation Trust,London,UK [2]MRC Clinical Trials Unit at UCL,London,UK [3]UCL Cancer Institute,London,UK [4]Department of Gastrointestinal Oncology,North Middlesex University Hospital,London,UK

出　　处：《Hepatobiliary Surgery and Nutrition》2021年第2期276-278,共3页肝胆外科与营养（英文）

摘　　要：Approximately 25%of individuals with colorectal cancer(CRC)present with metastatic disease,and it is estimated that throughout the course of the disease,up to 50%of individuals may develop liver metastases,the majority of which are unresectable(1).However,thermal ablation is a treatment modality increasingly used to manage individuals with liver metastases.Recently Takahashi et al.published a comprehensive review of the various approaches to thermal ablation and summarised the recent evidence demonstrating an associated survival benefit supporting its use in the management of metastatic CRC(mCRC)(2).It is however critical to analyse the studies evaluated to ensure the strength of the evidence presented.

关 键 词：COLORECTAL METASTASES LIVER 

分 类 号：R73[医药卫生—肿瘤]